Folgen
Clarissa Gerhauser
Clarissa Gerhauser
Group Leader, German Cancer Research Center (dkfz.) Heidelberg
Bestätigte E-Mail-Adresse bei dkfz.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Pan-cancer analysis of whole genomes
ICGC-TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature 578 (7793), 82, 2020
11472020
Nuclear factor κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms
E Heiss, C Herhaus, K Klimo, H Bartsch, C Gerhäuser
Journal of Biological Chemistry 276 (34), 32008-32015, 2001
7322001
Glucosinolates in Brassica vegetables: The influence of the food supply chain on intake, bioavailability and human health
R Verkerk, M Schreiner, A Krumbein, E Ciska, B Holst, I Rowland, ...
Molecular nutrition & food research 53 (S2), S219-S219, 2009
6582009
Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop
C Gerhauser, A Alt, E Heiss, A Gamal-Eldeen, K Klimo, J Knauft, ...
Molecular Cancer Therapeutics 1 (11), 959-969, 2002
6182002
Beer constituents as potential cancer chemopreventive agents
C Gerhäuser
European Journal of Cancer 41 (13), 1941-1954, 2005
4632005
Mechanism-based in vitro screening of potential cancer chemopreventive agents
C Gerhäuser, K Klimo, E Heiss, I Neumann, A Gamal-Eldeen, J Knauft, ...
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523 …, 2003
4222003
Cancer chemopreventive potential of apples, apple juice, and apple components
C Gerhauser
Planta Med. 74 (13), 1608-1624, 2008
3882008
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes
C Gerhäuser, M You, J Liu, RM Moriarty, M Hawthorne, RG Mehta, ...
Cancer Research 57 (2), 272-278, 1997
3811997
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer
J Weischenfeldt, R Simon, L Feuerbach, K Schlangen, D Weichenhan, ...
Cancer cell 23 (2), 159-170, 2013
3802013
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer
A Krohn, T Diedler, L Burkhardt, PS Mayer, C De Silva, ...
The American journal of pathology 181 (2), 401-412, 2012
3662012
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage
RG Mehta, J Liu, A Constantinou, CF Thomas, M Hawthorne, M You, ...
Carcinogenesis 16 (2), 399-404, 1995
2891995
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation
M Jung, G Brosch, D Kölle, H Scherf, C Gerhäuser, P Loidl
Journal of medicinal chemistry 42 (22), 4669-4679, 1999
2591999
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer
D Brocks, Y Assenov, S Minner, O Bogatyrova, R Simon, C Koop, ...
Cell Reports 8 (3), 798-806, 2014
2532014
Cancer chemoprevention and nutri-epigenetics: state of the art and future challenges
C Gerhauser
Natural products in cancer prevention and therapy, 73-132, 2013
2402013
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
D Brocks, CR Schmidt, M Daskalakis, HS Jang, NM Shah, D Li, J Li, ...
Nature genetics 49 (7), 1052-1060, 2017
2342017
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention
E Bertl, H Bartsch, C Gerhauser
Molecular cancer therapeutics 5 (3), 575-585, 2006
2192006
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.
C Bock, F Halbritter, FC Carmona, S Tierling, P Datlinger, Y Assenov, ...
Nature Biotechnology 34 (7), 726-737, 2016
2122016
Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol …
C Gerhäuser
Molecular nutrition & food research 49 (9), 827-831, 2005
2022005
Cancer chemoprevention by targeting the epigenome
J Huang, C Plass, C Gerhauser
Current drug targets 12 (13), 1925-1956, 2011
1962011
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories
C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ...
Cancer Cell 34 (6), 996-1011. e8, 2018
1852018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20